An omniphobic lubricant-infused coating produced by chemical vapor deposition of hydrophobic organosilanes attenuates clotting on catheter surfaces

被引:101
作者
Badv, Maryam [1 ]
Jaffer, Iqbal H. [2 ,3 ]
Weitz, Jeffrey I. [1 ,2 ,4 ]
Didar, Tohid F. [1 ,5 ]
机构
[1] McMaster Univ, Sch Biomed Engn, Hamilton, ON, Canada
[2] Thrombosis & Atherosclerosis Res Inst TaARI, Hamilton, ON, Canada
[3] McMaster Univ, Dept Surg, Hamilton, ON, Canada
[4] McMaster Univ, Dept Med & Biochem & Biomed Sci, Hamilton, ON, Canada
[5] McMaster Univ, Dept Mech Engn, Hamilton, ON, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
BLOOD COMPATIBILITY; IN-VITRO; THROMBOSIS; PROTEINS; IMMOBILIZATION; CHEMISORPTION; ADSORPTION; GOLD;
D O I
10.1038/s41598-017-12149-1
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Catheter associated thrombosis is an ongoing problem. Omniphobic coatings based on tethering biocompatible liquid lubricants on self-assembled monolayers of hydrophobic organosilanes attenuate clotting on surfaces. Herein we report an efficient, non-invasive and robust process for coating catheters with an antithrombotic, omniphobic lubricant-infused coating produced using chemical vapor deposition (CVD) of hydrophobic fluorine-based organosilanes. Compared with uncoated catheters, CVD coated catheters significantly attenuated thrombosis via the contact pathway of coagulation. When compared with the commonly used technique of liquid phase deposition (LPD) of fluorine-based organosilanes, the CVD method was more efficient and reproducible, resulted in less disruption of the outer polymeric layer of the catheters and produced greater antithrombotic activity. Therefore, omniphobic coating of catheters using the CVD method is a simple, straightforward and non-invasive procedure. This method has the potential to not only prevent catheter thrombosis, but also to prevent thrombosis on other blood-contacting medical devices.
引用
收藏
页数:10
相关论文
共 41 条
[1]   Albumin-coated vascular prostheses: A five-year follow-up [J].
AlKhaffaf, H ;
Charlesworth, D .
JOURNAL OF VASCULAR SURGERY, 1996, 23 (04) :686-690
[2]  
Berg T. A., 2010, Minnesota, US patent, Patent No. 7674411
[3]   Pump-induced platelet aggregation in albumin-coated extracorporeal systems [J].
Borgdorff, P ;
van den Berg, RH ;
Vis, MA ;
van den Bos, GC ;
Tangelder, GJ .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1999, 118 (05) :946-952
[4]   Protein repellant silicone surfaces by covalent immobilization of poly(ethylene oxide) [J].
Chen, H ;
Zhang, Z ;
Chen, Y ;
Brook, MA ;
Sheardown, H .
BIOMATERIALS, 2005, 26 (15) :2391-2399
[5]   An immobilized liquid interface prevents device associated bacterial infection in vivo [J].
Chen, Jiaxuan ;
Howell, Caitlin ;
Haller, Carolyn A. ;
Patel, Madhukar S. ;
Ayala, Perla ;
Moravec, Katherine A. ;
Dai, Erbin ;
Liu, Liying ;
Sotiri, Irini ;
Aizenberg, Michael ;
Aizenberg, Joanna ;
Chaikof, Elliot L. .
BIOMATERIALS, 2017, 113 :80-92
[6]   Structural, Physical, and Chemical Properties of Fluorous Compounds [J].
Gladysz, John A. ;
Jurisch, Markus .
FLUOROUS CHEMISTRY, 2012, 308 :1-23
[7]  
GUIDOIN RG, 1976, BIOMATER ARTIF CELL, V4, P205, DOI 10.3109/10731197609118651
[8]   Whole blood coagulation on protein adsorption-resistant PEG and peptide functionalised PEG-coated titanium surfaces [J].
Hansson, KM ;
Tosatti, S ;
Isaksson, J ;
Wetterö, J ;
Textor, M ;
Lindahl, TL ;
Tengvall, P .
BIOMATERIALS, 2005, 26 (08) :861-872
[9]   Effect of pegylation on pharmaceuticals [J].
Harris, JM ;
Chess, RB .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (03) :214-221
[10]   Design and characterization of PEGylated terpolymer biomaterials [J].
Heath, Daniel E. ;
Cooper, Stuart L. .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2010, 94A (04) :1294-1302